share_log

Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY

Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY

Chemomab Therapeutics第四季度每股收益美元(0.26美元)高于同比增长0.72美元
Moomoo 24/7 ·  03/07 07:06

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losses of $(0.72) per share from the same period last year.

Chemomab Therapeutics(纳斯达克股票代码:CMMB)报告称,季度每股亏损为0.26美元。这比去年同期每股亏损0.72美元(0.72美元)增长了63.89%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发